# 2% LIDOCAINE HCI

NDC: 51662-1231
Generic name: 2% LIDOCAINE HCI
Labeler / Manufacturer: HF Acquisition Co. LLC, DBA Health First
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180825

FDA application: ANDA083158

## Active ingredients

- LIDOCAINE HYDROCHLORIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1231"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1231
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74450548-62f4-b77f-e053-2991aa0ae5cf